safe glp 1 alternative Safety risks in the GLP-1 market: an update on weight loss medication, May 2026 – Partnership for Medicines Alternatives - Nutrition and Nourishment

"Pfizer, when it plays, plays big, and we will, as we did in COVID, as with Lipitor, as [with] Viagra, with all the medicines that we have invented and brought to the market, we will do the same with obesity," Bourla said Thursday on "Mornings with Maria." The deal allows the pharmaceutical giant to secure the rights to new weight-loss treatments still in trials, entering a space already crowded with popular GLP-1 drugs like Eli Lilly's Zepbound and Novo Nordisk's Wegovy

While I'm excited that patients may soon have more options, enthusiasm should not blind us to the risks

For a broader look at how different supplement forms compare, this guide on supplement absorption and bioavailability from Examine is worth reading

doi: 10.1186/1741-7015-9-48 27